key: cord-0999394-xzfe21zc
authors: Koloteva, Anna; Odintsova, Galina
title: Structural epilepsies in patients with coronavirus infection on admission to an urban emergency hospital (Pokrovskaya City Hospital, in St. Petersburg)
date: 2021-10-31
journal: Journal of the Neurological Sciences
DOI: 10.1016/j.jns.2021.119845
sha: 69973936073cdcb4ddecfb9156ba5df33c95ef91
doc_id: 999394
cord_uid: xzfe21zc

nan

longitudinal study done in a population of hospitalized patients in Brescia.

First studies show that not only clinical but also biopsychosocial effects are becoming increasingly important as long as more data are collected.

Although further research is needed to understand which patients are most vulnerable to neurological manifestations in the acute, long or post COVID-19 disease, however after this first year it is clear that neurological, biopsychosocial and mental health data need to be not only collected but also analysed in a manner that could help the understanding of characteristics, timing, and severity of neurological manifestations of COVID-19. 

Lower motor neurone facial nerve palsies are a rare complication of SARS-CoV-2 infection. Bell's palsy following COVID myocarditis has been reported previously but whether they are associated is not known. We report the first case of the above combination in pregnancy.

A 27-year-old Sri Lankan in her 2nd pregnancy complicated with pregnancy induced hypertension since POA of 26 weeks presented at 30 weeks with fever, productive cough and exertional dyspnoea for 4 days. She was tachypnoeic (RR-40 min) and tachycardic (PR-120 min). There was a left-sided mild pleural effusion (later confirmed by ultrasound) with clear lung fields (SpO2-97%). The ECG had widespread T inversions and ST-depressions, 2D-Echo had global hypokinesia with a thin rim of pericardial fluid. Serum troponins were marginally elevated (0.4 ng/ml). She had a neutrophil leucocytosis with elevated ESR (120 mm/h), CRP (291 mg/l) and D-dimers (1249 ng/ml). Deep vein thrombosis and pulmonary embolism were excluded by imaging. Blood and urine cultures were negative. The SARS-CoV-2 PCR was weakly positive with a strong positivity for COVID antibodies. Serology for enterovirus, rickettsia, Legionella and Mycoplasma were negative. She had an uneventful recovery after a hospital stay of 2 weeks managed symptomatically and with prophylactic antibiotics.

One-week post-discharge she presented a left sided Bell's palsy without other neurological signs, symptoms; a phenomenon reported by many. She was treated with Galvanic stimulation and oral steroids for 10 days and made an uneventful recovery in 2 weeks.

COVID in pregnancy is a predisposition to Bell's palsy. It's association with myocarditis should be sought. 

Clinical analysis was carried out in 50 patients who applied to the TMA clinic. The average age of patients was 60 ± 9.0 years, including 27 women (54%) and 23 men (46%), with diagnosis of cavernous sinus thrombosis, osteomyelitis of jaw 1-3 months after the onset of acute COVID-19 disease. During the 10-day period of hospitalization and 6 months of rehabilitation, the pain was assessed according to a 10-point criterion (pain load -0 points, very strong -10 points) through the questionnaire.

N. Facialis paresis was in 39 patients, paresthesia of the 3rd corneal nerve in 28 patients. Local pain was observed in 15% of the head, 50% irradiated to facial nerve and 35% in the area of facial inflammation. After the first 10 days of treatment, pain decreased from 10 to 2.5 points in 35% of patients. Severe pain was observed in 10% of patients (8-10 points), and in 25% of patients, the average simultaneous pain in the local jaw area remained within 3.5 ± 0.38 (p ≥ 0.05). In 15% of patients, the headache persisted up to 4-5 (on average) points, in 15% of patients the headache completely disappeared. The mean pain score was 2.6 ± 0.3 (p ≥ 0.05) in all patients older than 6 months.

In patients undergoing COVID-19, with thrombosis, facial necrosis severe pain persisted long time. Results 12% (7) reported a fatal outcome (seizures in acute stroke period//epilepsy+severe COVID-19//symptomatic epilepsy metastases in brain + In 81% (46), COVID-19 was successfully treated. In 7% (4), a transfer to another specialized hospital.

Olfactory dysfunction is emerging as a key symptom of COVID-19 along with other neurological complications. Herein we describe a case of persistent cacosmia with an unusual finding on brain MRI.

In March 2020, a 50-year-old woman with no relevant medical history developed fever, dry cough, diffuse muscle pain, sudden onset of anosmia and ageusia. She was diagnosed with COVID-19 by positive result on PCR analysis. Her clinical course was uncomplicated. Anosmia and ageusia started improving after two months. However, during the recovery phase she started perceiving distorted and unpleasant smells in response to stimuli (cacosmia) as well as sudden unpleasant smell sensations without any odorant stimuli (phantosmia). These symptoms persisted for 9 months, therefore she was referred to our neurology clinic.

Neurological objective examination was normal. EEG with olfactory stimulation showed a normal pattern. Brain MRI was performed after 10 months from the onset of symptoms. 3D FLAIR images showed an evident cortical hyperintensity in the medial olfactory stria and in the adjoining cortex of the subcallosal gyrus ( Figs. 1-2 ).

This report shows an unprecedented signal alteration on MRI in a patient with persistent cacosmia and phantosmia 10 months after SARS-CoV-2 infection, reinforcing the hypothesis of SARS-CoV-2 neurotropic propagation through the olfactory system. 

Guillain-Barré syndrome consists group of clinical syndromes that manifests as an acute or subacute autoimmune inflammatory polyradiculoneuropathy with resultant weakness and diminished reflexes. It is also part of so-called Yuki syndrome. Its annual

An epilepsy episode developed for the first time -33

Epilepsy episodes have been reported before -49.1% (28)

According to the etiology of the epilepsy syndrome

The background of acute neurological disorder (cerebral edema: acute stroke period//newly detected large brain mass

The background of exogenous intoxication by alcohol and psychoactive substances -25

Unclear etiology -19

Poststroke seizure -12

Symptomatic epilepsy (the background of brain masses) -8.8% (0-0-5)

Conclusions Frequency of admission "COVID-19 + epilepsy syndrome

The etiology of exogenous intoxication still predominates

The mortality in the cohort is not higher than in other groups

Gianpaolo Basso c , Carlo Ferrarese ad